Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience
Abstract:BackgroundThe use of left ventricular assist devices (LVADs) has gained significant importance for treatment of end-stage heart failure. Fast-track procedures are well established in cardiac surgery, whereas knowledge of their benefits after LVAD implantation is sparse. We hypothesized that ultra-fast-track anesthesia (UFTA) with in-theater extubation or at a maximum of 4 h. after surgery is feasible in Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) level 3 and 4 patients and mi… Show more
“…The goal of fast‐track cardiac anesthesia is to reduce stress, relieve pain, and speed recovery, reduce hospitalization costs, and save medical resources. This technology's fundamental purpose is to replace long‐acting opioids with short‐acting opioids or to reduce the dosage of long‐acting opioids combined with inhaled anesthetics and other short‐acting intravenous anesthetics to achieve early recovery of spontaneous breathing and circulation 5,6,13–15 . Fast‐track anesthesia has been applied and studied in pediatric congenital cardiac surgery, but its application in transthoracic device closure of pediatric congenital VSDs under TEE guidance is rarely reported.…”
Background: This study aimed to evaluate the analgesic and sedative effects of remifentanil-based fast-track cardiac anesthesia in children undergoing transthoracic device closure of ventricular septal defects (VSDs). Methods: A retrospective analysis was conducted on 62 children who underwent transthoracic device closure of VSDs from May 2019 to August 2019. The patients were divided into two groups based on the anesthesia methods: group F was given remifentanil-based fast-track cardiac anesthesia, and Group C was given conventional anesthesia. Patient-related clinical data, postoperative analgesia scores, and sedation scores were collected and analyzed. Results: There was no significant difference in intraoperative hemodynamic changes, bispectral index values, postoperative analgesia scores, sedation scores, or the incidence of adverse events between the two groups. Compared with Group C, the duration of mechanical ventilation and the length of intensive care unit (ICU) and hospital stay in group F were significantly lower. Conclusion: Remifentanil-based fast-track anesthesia can be safely applied in children undergoing transthoracic device closure of VSDs, with acceptable postoperative analgesia and sedation effects and shorter mechanical ventilation times and ICU and hospital stays compared with conventional anesthesia. K E Y W O R D S analgesic, fast-track anesthesia, remifentanil, sedative, VSD 1 | BACKGROUND A ventricular septal defect (VSD) is one of the most common cardiac malformations, accounting for 40% of all cardiac malformations. 1 Surgical repair and percutaneous device closure of VSDs are the two most commonly used methods in clinical practice. 2 In recent years, transthoracic device closure of VSDs without extracorporeal circulation, which is another possible treatment, has been widely used and reported in China. Transthoracic device closure of VSDs has the advantages of a small incision, rapid recovery, fewer complications,
“…The goal of fast‐track cardiac anesthesia is to reduce stress, relieve pain, and speed recovery, reduce hospitalization costs, and save medical resources. This technology's fundamental purpose is to replace long‐acting opioids with short‐acting opioids or to reduce the dosage of long‐acting opioids combined with inhaled anesthetics and other short‐acting intravenous anesthetics to achieve early recovery of spontaneous breathing and circulation 5,6,13–15 . Fast‐track anesthesia has been applied and studied in pediatric congenital cardiac surgery, but its application in transthoracic device closure of pediatric congenital VSDs under TEE guidance is rarely reported.…”
Background: This study aimed to evaluate the analgesic and sedative effects of remifentanil-based fast-track cardiac anesthesia in children undergoing transthoracic device closure of ventricular septal defects (VSDs). Methods: A retrospective analysis was conducted on 62 children who underwent transthoracic device closure of VSDs from May 2019 to August 2019. The patients were divided into two groups based on the anesthesia methods: group F was given remifentanil-based fast-track cardiac anesthesia, and Group C was given conventional anesthesia. Patient-related clinical data, postoperative analgesia scores, and sedation scores were collected and analyzed. Results: There was no significant difference in intraoperative hemodynamic changes, bispectral index values, postoperative analgesia scores, sedation scores, or the incidence of adverse events between the two groups. Compared with Group C, the duration of mechanical ventilation and the length of intensive care unit (ICU) and hospital stay in group F were significantly lower. Conclusion: Remifentanil-based fast-track anesthesia can be safely applied in children undergoing transthoracic device closure of VSDs, with acceptable postoperative analgesia and sedation effects and shorter mechanical ventilation times and ICU and hospital stays compared with conventional anesthesia. K E Y W O R D S analgesic, fast-track anesthesia, remifentanil, sedative, VSD 1 | BACKGROUND A ventricular septal defect (VSD) is one of the most common cardiac malformations, accounting for 40% of all cardiac malformations. 1 Surgical repair and percutaneous device closure of VSDs are the two most commonly used methods in clinical practice. 2 In recent years, transthoracic device closure of VSDs without extracorporeal circulation, which is another possible treatment, has been widely used and reported in China. Transthoracic device closure of VSDs has the advantages of a small incision, rapid recovery, fewer complications,
“…Sevoflurane was a commonly used inhalation anesthetic, and atracurium was an auxiliary anesthetic; all of them were safe and effective and high tolerance for the patients [ 29 ]. Fast-track anesthesia could effectively avoid stress stimulation of patients, promote the prognosis of patients, improve the effectiveness of surgical treatment, and reduce the days of hospitalization [ 30 ].…”
Objective
To investigate the effect of remifentanil-based fast-track anesthesia on analgesia and sedation after transthoracic device closure of ventricular septal defects (VSDs) in adult patients.
Methods
A retrospective analysis was performed on 59 patients aged 21–53 years who underwent transthoracic device closure of VSDs from January 2019 to September 2019. According to the different anesthesia strategies, the patients were divided into the R group (using remifentanil-based anesthesia, n = 33) and the S group (using sufentanil-based anesthesia, n = 26). Patient-related clinical data, postoperative analgesia, and sedation scores were collected and analyzed.
Results
There was no significant difference in age, gender, body weight, and operation time between the group R and the group S (P > 0.05). There was also no significant difference in intraoperative hemodynamic changes, BIS scores, postoperative analgesia, and sedation scores between the two groups (P > 0.05). The duration of mechanical ventilation, the length of ICU stay, and hospital stay in the group R were significantly lower than those in the group S (P < 0.05).
Conclusion
Remifentanil-based fast-track anesthesia is effective for adult patients undergoing transthoracic device closure of VSDs, which may shorten the mechanical ventilation duration, the ICU and hospital stay of patients.
“…It is correlated with lower rates of respiratory complications and lower use of resources and becomes a common goal of postoperative recovery after cardiac surgery. [2,3] Weaning from mechanical ventilatory support (MVS) continues to be an erroneous technique and dependent mainly on clinicians' experiences. Some parameters and calculated formulas like the ratio of respiratory frequency (f ) to tidal volume(Vt)-also known as rapid shallow breath index (RSBI) -is used widely to standardize weaning from MVS and to predict failure of attempt.…”
Introduction: Overnight postoperative ventilation following cardiovascular surgery was a routine procedure since 1960 and the usage of high-dose opioid anesthetic techniques strengthens the need. However early extubation of postcardiac patients has been claimed as safer and more cost-effective approach. Rapid shallow breath index (RSBI) is used widely to standardize weaning from Mechanical ventilatory support (MVS) and to predict failure of attempt. The aim of this retrospective study was to determine the impact of early extubation on post-cardiovasular surgery patients and the possible correlations of RSBI values. Methods: This retrospective analysis was performed including 230 consecutive patients-who underwent cardiac surgery from September 2017 to January 2018 in a tertiary state hospital. Results: There was significant difference between early extubated group and conventional group in the prevalence of comorbidities, duration of surgery, LOS in hospital and in the ICU. There was no significant difference between groups either in mechanical ventilation parameters including RSBI, mortality or morbidity. Discussion and Conclusion: Early extubation offers a substantial advantage in terms of accelerated recovery, shorter intensive care unit, and hospital stay, suggesting that efforts to reduce extubation times are cost-effective. Early Extubation following cardiac surgery can be managed in a successful manner and comparing to conventional practices it saves valuable hours of patients. RSBI, in the original cutoff point, was found useless as a weaning parameter while the threshold value for weaning failure was 31.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.